share_log

【中信建投证券】双成药业:独放争春

[CSC FINANCIAL CO.,LTD] Shuangcheng Pharmaceutical Co., Ltd.: fight for spring alone

中信建投證券 ·  Aug 1, 2012 00:00  · Researches

Profit forecast and valuation

It is estimated that the EPS of the company from 2012 to 2014 is 0.68,0.87 and 0.97 yuan respectively. With reference to the price-to-earnings ratio of similar listed companies and the characteristics of the company's product structure, the company is given 25-28 times PE in 2012, corresponding to a reasonable price range of 17-19.04 yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment